| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |